Final Results

RNS Number : 7347U
CareCapital Group plc
30 June 2009
 




30 June 2009



CARECAPITAL GROUP PLC

("CareCapital" or "the Company")


Financial statements for the year to 31 December 2008


CareCapital plc (AIM: CARE), the healthcare real estate developer and owner, is pleased to announce its audited financial statements for the year to 31 December 2008.


Highlights

    Group rental income up 35% to £2.86 million (2007: £2.12 million).

    Portfolio value up 31% to £52.3 million (2007: £39.9 million).

    Rent reviews for the year have produced an average increase of 10.4%.

    Completion of two developments with a combined value of £8.9 million.

    Development programme in the UK and Germany with a value of £87 million.


Chairman's statement


I am pleased to present the 2008 financial results for CareCapital Group Plc and report on activities during the year and since my last year end statement published on 25 June 2008.


Good progress has been achieved during the period under review despite the prevailing economic conditions. In the UK, the 1,200m sq. dental/medical facility in Folkestone has been completed and the projects in Southampton and Coventry are being progressed with the objective of construction commencing in the late summer/early autumn this year. Additionally, the other projects in our development pipeline are being moved forward in line with their projected timetables in both the UK and Germany. In Germany, we have completed the 3,300m sq. development in Marktredwitz, Northern Bavaria, which is fully let and also commenced construction on a 3,600m sq. medical office building south east of Berlin; this pre-let facility is scheduled for completion in the early spring next year. Pre-letting is well advanced on a further development project in central Berlin. 


At 31 December 2008 the value of our completed investment properties had increased to £52.3 million (2007: £39.9 million) and developments in progress to £3.5 million (2007: £3.1 million). We now have 103 tenants in 26 completed buildings generating £3.06 million (2007: £2.36 million) in rental income on an annualised basis.


Independent valuation reviews have been conducted in respect of both the UK and German property portfolios. Although the valuation of the German properties (representing 48.9% of the overall portfolio) was in line with previous valuations, the UK value was reduced by £2.03 million as a consequence of the then current market conditions. This adjustment, offset to an extent by uplifts in value on completed developments and increases in value resulting from rent reviews, has been charged against profit and is largely the reason for reporting a loss for 2008 of £1.69 million after tax (2007: £1.51 million profit).


The underlying strength in terms of tenant covenant and the requirement to expand services at the community level has meant that the perceived softening of capital yields in the medical office building sector has had a far lesser impact than the property market generally and this is reflected in our continuing ability to secure development funding and long term debt financing from our panel of banks on competitive terms and at relatively high loan to value ratios. 


In order to maintain the momentum of our development programme we successfully completed two general financings for the Company during 2008; raising £3.9 million through the refinancing of a substantial part of the UK portfolio and a further £4 million by way of a short term mezzanine loan.


We are currently negotiating an additional financing which will ensure the fulfilment of our current developments and enable further expansion beyond that programme. It is anticipated this funding will be completed before the end of September.


The past twelve months have been a challenge in a number of ways for the Company not least as a result of the prevailing economic conditions. It is a reflection of the skills and experience of our staff that these challenges are overcome and the Company continues to make significant progress."


Dr. Michael Sinclair

Chairman

29 June 2009





Consolidated income statement

For the year ended 31 December 2008



Group

2008

Group

2007


£

£




Continuing operations



Revenue

2,856,110

2,115,026

Cost of sales

(416,025)

(162,806)

Gross profit

2,440,085

1,952,220

Administrative expenses

(1,750,826)

(1,845,788)

Other operating income

-

126,180

Net (deficit)/surplus on revaluation of investment properties

(1,655,932)

2,507,319

Operating (loss)/profit

(966,673)

2,739,931

Finance income

1,208,929

257,872

Finance costs

(2,548,868)

(1,351,164)

Change in fair value of financial instruments

92,256

7,239

Net finance costs

(1,247,683)

(1,086,053)

(Loss)/profit before tax

(2,214,356)

1,653,878

Taxation

524,195

(144,290)

(Loss)/profit after taxation

(1,690,161)

1,509,588

Discontinued operations



Loss from discontinued operations

-

(27,965)

(Loss)/profit for the period



- attributable to equity shareholders

(1,688,027)

1,353,187

- attributable to minority interest

(2,134)

128,436


(1,690,161)

1,481,623

(Loss)/earnings per ordinary share



Basic - total

(2.20)p

1.76p

- continuing operations

(2.20)p

1.76p

- discontinued operations

-

-

Diluted - total

(2.20)p

1.72p

- continuing operations

(2.20)p

1.72p

- discontinued operations

-

-

Weighted average number of shares (000')

76,754

76,754




Consolidated balance sheet

As at 31 December 2008


Group

2008

Group

2007


£

£

Non-current assets



Goodwill

1,751,959

1,751,959

Investment properties

52,331,824

39,931,316

Development properties

3,512,716

3,086,413

Leasehold improvements

79,914

89,315

Plant and equipment

58,941

56,467


57,735,354

44,915,470

Current assets



Trade and other receivables

465,181

546,145

Cash and cash equivalents

2,519,519

118,680


2,984,700

664,825

Total assets

60,720,054

45,580,295

Current liabilities



Trade and other payables

(1,940,940)

(790,472)

Borrowings, including finance leases

(4,438,452)

(2,393,676)

Derivative financial instruments

-

(92,256)


(6,379,392)

(3,276,404)

Non-current liabilities



Borrowings, including finance leases

(38,327,667)

(24,745,982)

Deferred tax

(2,103,420)

(2,627,615)


(40,431,087)

(27,373,597)

Total liabilities

(46,810,479)

(30,650,001)

Net assets

13,909,575

14,930,294

Equity



Share capital

767,541

767,541

Share premium account

1,397,500

1,397,500

Share option reserve

390,606

209,332

Reverse acquisition reserve

11,038,204

11,038,204

Exchange movements reserve

443,404

4,053

Profit and loss account

(303,469)

1,384,558

Equity attributable to shareholders of the Parent

13,733,786

14,801,188

Minority Interest

175,789

129,106

Total equity

13,909,575

14,930,294




Consolidated cash flow statement

For the year ended 31 December 2008




Group

2008

Group

2007


£

£

Cash flows from operating activities



(Loss)/profit after taxation

(1,690,161)

1,481,623

Adjustments:



Taxation

(524,195)

144,290

Change in fair value of financial instruments

(92,256)

(7,239)

Finance costs

2,548,868

1,351,164

Finance income

(1,208,929)

(257,872)

Unrealised net revaluation losses/(gains) on investment properties

1,655,932

(2,507,319)

Profit on sale of property

-

(126,180)

Depreciation

38,460

33,709

Write off of development costs incurred

16,933

15,456

Share based payments

21,649

66,277

Cash flows from operations before changes in working capital

766,301

193,909

Change in trade and other receivables

(13,770)

13,325

Change in trade and other payables

808,538

(281,429)

Cash generated/(used) from operations

1,561,069

(74,195)

Interest paid

(2,186,557)

(1,338,024)

Cash flows from operating activities

(625,488)

1,412,219)

Cash flows from investing activities



Purchase of investment property

(520,845)

7,349,714)

Sale of non-current asset held for sale

-

1,626,180

Capital expenditure on development properties

(8,461,421)

(2,596,953)

Purchase of leasehold improvements

(400)

(96,305)

Purchase of plant and equipment

(31,133)

(55,470)

Sale of plant and equipment

-

440

Interest received

10,933

59,564

Cash flows from investing activities

(9,002,866)

(8,412,258)

Cash flows from financing activities



New mortgage loans raised (net of transaction costs)

22,868,788

6,519,028

Repayment of loans

(12,588,154)

(403,651)

Repayment of finance leases

-

(8,041)

Repayment of loan on non-current asset held for sale

-

(468,539)

Directors' loan (net of costs)

3,666,724

-

Cash flows from financing activities

13,947,358

5,638,797

Increase/(decrease) in cash and cash equivalents

4,319,004

(4,185,680)

Cash and cash equivalents at 1 January

(1,863,747)

2,321,933

Cash and cash equivalents at 31 December

2,455,257

(1,863,747)




Consolidated statement of changes in equity


For the year ended 31 December 2008



Share capital

£

Share premium

£

Share options reserve

£

Reverse acquisition reserve

£

Exchange rate movement reserve

£

Profit and loss account

£

Equity share-holders' interest

£

Minority interest

£

Total

£

Balance at 1 January 2007

767,541

1,397,500

143,055

11,038,204

-

31,371

13,377,671

-

13,377,671


Exchange rate movement

-

-

-

-

4,053

-

4,053

450

4,503


Profit for the year

-

-

-

-

-

1,353,187

1,353,187

128,436

1,481,623


Total recognised income and expenditure

-

-

-

-

4,053

1,353,187

1,357,240

128,886

1,486,126


Share based payment











 - employee services*

-

-

66,277

-

-

-

66,277

-

66,277


Minority interest in subsidiary

-

-

-

-

-

-

-

220

220


Balance at 31 December 2007

767,541

1,397,500

209,332

11,038,204

4,053

1,384,558

14,801,188

129,106

14,930,294


Balance at 1 January 2008

767,541

1,397,500

209,332

11,038,204

4,053

1,384,558

14,801,188

129,106

14,930,294


Exchange rate movement

-

-

-

-

439,351

-

439,351

48,817

488,168


Loss for the year

-

-

-

-

-

(1,688,027)

(1,688,027)

(2,134)

(1,690,161)


Total recognised income and expenditure

-

-

-

-

439,351

(1,688,027)

(1,248,676)

46,683

(1,201,993)


Share based payment











 - employee services

-

-

21,649

-

-

-

21,649

-

21,649


 - costs of raising finance

-

-

159,625

-

-

-

159,625

-

159,625


Balance at 31 December 2008

767,541

1,397,500

390,606

11,038,204

443,404

(303,469)

13,733,786

175,789

13,909,575



Notice of Annual General Meeting


Notice is hereby given that the Annual General Meeting of CareCapital Group Plc ("the Company") will be held at 54 Baker Street, London W1U 7BU on Wednesday, 29 July 2009 at 10.00 a.m. Details of the resolutions proposed are included in the Notice of the Annual General Meeting which will be posted to shareholders on 3 July 2009 and is available on the Company's web site at www.carecapital.co.uk

Financial Statements & Audit Opinion

The financial information included in this preliminary results announcement for the years ended 31 December 2008 and 31 December 2008 does not comprise statutory accounts within the meaning of section 240 of the Companies Act 1985. It represents an extract from the statutory accounts, which have not yet been delivered to the Registrar of Companies. Statutory accounts for the year ended 31 December 2008 were today approved by the Board of directors and delivered to the Registrar of Companies.


In forming their opinion, which was not qualified, the auditors have considered the adequacy of the disclosure made in accounting policy (a) to the financial statements concerning the Group's ability to continue as a going concern. The Group had net current liabilities of £3.4 million at 31 December 2008 and has commitments to develop new properties. As a result, the Group requires further funding to meet it debt repayment, development programme and working capital requirements. These conditions, along with the other matters explained in accounting policy (a) to the financial statements, indicate the existence of a material uncertainty which may cast significant doubt about the Group's ability to continue as a going concern. The financial statements do not include the adjustments that would result if the Group was unable to continue as a going concern.


Publication of the Annual Report & Accounts


Copies of the Annual Report & Accounts have today been posted on the Company's web site at www.carecapital.co.uk. Printed copies of the financial statements will be posted to shareholders on 3 July 2009.


For further information please visit www.carecapital.co.uk or contact:

Paul Stacey, Managing Director

Steve Wilden, Finance Director

Simon Leathers

Simon Hudson, 

Paul Young

CareCapital Group Plc

Daniel Stewart & Co. Plc

Tavistock Communications

Tel: 020 7034 1949

Tel: 020 7776 6566

Tel: 020 7920 3150

pstacey@carecapital.co.uk

simon.leathers@danielstewart.co.uk

shudson@tavistock.co.uk 

swilden@carecapital.co.uk


pyoung@tavistock.co.uk


~ ends ~


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR CKCKDKBKBOAB
UK 100

Latest directors dealings